Tapan M. Kadia

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Tapan M. Kadia
Feb 27, 2025, 11:09 | Science
Nitin Jain: Treatment-free remission in Ph+ ALL
Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared…
Feb 26, 2025, 16:33 | Science
Hagop Kantarjian: Treatment-free remission in non-transplanted Ph+ ALL patients
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas…
Feb 19, 2025, 10:20 | Blog
Hagop Kantarjian: Impact of MRD clearance kinetics in patients with AML undergoing intensive chemotherapy
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas…
Dec 26, 2024, 14:37 | Insight
Jayastu Senapati: Largest reported cohort in secondary AML
Jayastu Senapati, Assistant Professor of Leukemia at MD Anderson Cancer Center, shared on X: “Check…
Dec 16, 2024, 18:10 | Insight
Cellenkos Presented Results of Phase 1b Data for CK0804 T-Regulatory Cell Therapy in Myelofibrosis at ASH 2024
Innovative Cellular Therapy Demonstrated Safety and Potential Clinical Benefit at ASH 2024 Cellenkos, a clinical-stage…
Dec 8, 2024, 06:21 | Insight
Understanding and treating myelofibrosis
Nico Gagelmann shared a post on X: "Understanding and treating myelofibrosis A short thread on…
Dec 4, 2024, 20:32 | Insight
Naveen Pemmaraju: Add-On Therapy with CK0804 in Myelofibrosis Patients with Suboptimal Response to Ruxolitinib
Naveen Pemmaraju shared a post on X: "Highlighting the wonderful work of Dr Lucia Masarova. Prelim/early…
Dec 2, 2024, 19:24 | Insight
Naveen Pemmaraju: PVO combination program for frontline CLL treatment
Naveen Pemmaraju shared a post on X: '' ASH Kudos to Dr. Nitin Jain for an…
Dec 2, 2024, 17:59 | Insight
Naveen Pemmaraju: Pre-clinical Investigation of Tasquinimod for AML Following Myeloproliferative Neoplasm
Naveen Pemmaraju shared a post on X: "Check out our novel Myeloproliferative neoplasm abstract for ASH…
Jul 23, 2024, 22:30 | Blog
Hagop Kantarjian: The simultaneous combination of ponatinib and blinatumomab highly effective
Hagop Kantarjian shared on X: "The simultaneous combination of ponatinib and blinatumomab highly effective: MRD-negativity rate…
Jul 22, 2024, 13:23 | Blog
Naveen Pemmaraju: CK0801 in Treatment of Bone Marrow Failure Syndromes
Naveen Pemmaraju posted on X about recent paper by Tapan M. Kadia et al., commenting:…
Jul 19, 2024, 13:19 | Insight
Sanam Loghavi: Optical genome mapping in acute myeloid leukemia
Sanam Loghavi, shared a post on X about a recent paper titled "Optical genome mapping improves…
All: 12 Posts: 1 - 100
Special Coverage